Anaptysbio ANAB
NASDAQ ANAB
$48.53 -0.10 (-0.21%)
At close: Oct 2, 2026 · 4:00 PM EDT

Anaptysbio (ANAB) Cash from Investing Activities (2016 - 2026)

Updated

Anaptysbio (ANAB) posted Cash from Investing Activities of $34.98 million for Q1 2026, up 135.6% from $14.85 million a year earlier but down 52.4% from the prior quarter.

Analysis

Anaptysbio (ANAB) Cash from Investing Activities (2016 - 2026) Analysis & Trends

For the trailing twelve months through Mar 31, 2026, Cash from Investing Activities at Anaptysbio was $248.17 million, up 496.1% year-over-year; for FY2025, it was $228.03 million, up 139.0% from FY2024.

  • Annual Cash from Investing Activities shows a five-year compound annual growth rate of 19.3% (FY2020 to FY2025).
  • In prior years, Anaptysbio's Cash from Investing Activities was $95.4 million in FY2024 (-34.1%), $144.75 million in FY2023, -$394.85 million in FY2022 and $38.84 million in FY2021 (-58.9%).
  • Quarterly Cash from Investing Activities has run from a low of -$312.91 million in Q1 2022 to a high of $103.28 million in Q3 2025 over five years.
  • On a year-over-year basis, Cash from Investing Activities increased in three of the last four quarters, with growth averaging 56.2%.
  • The strongest year-over-year quarter for Cash from Investing Activities in the past five years was Q1 2026, with growth of 135.6%; the weakest was Q1 2025, with a decline of 78.4%.
  • According to Business Quant data, Cash from Investing Activities for the three prior quarters was $73.5 million (Q4 2025), $103.28 million (Q3 2025) and $36.4 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Anaptysbio 1.41 Bn 296.12 Mn - 34.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 34.98 Mn
Dec 31, 2025 73.50 Mn
Sep 30, 2025 103.28 Mn
Jun 30, 2025 36.40 Mn
Mar 31, 2025 14.85 Mn
Dec 31, 2024 -29.40 Mn
Sep 30, 2024 58.62 Mn
Jun 30, 2024 -2.44 Mn
Mar 31, 2024 68.62 Mn
Dec 31, 2023 49.18 Mn
Sep 30, 2023 30.64 Mn
Jun 30, 2023 -20.46 Mn
Mar 31, 2023 85.40 Mn
Dec 31, 2022 21.50 Mn
Sep 30, 2022 -32.43 Mn
Jun 30, 2022 -71.00 Mn
Mar 31, 2022 -312.91 Mn
Dec 31, 2021 -66.69 Mn
Sep 30, 2021 10.84 Mn
Jun 30, 2021 37.96 Mn
API Access

Anaptysbio Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ANAB&period=max&api_key=YOUR_API_KEY